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August 11, 2009:661–8. Myocardial inflammation. Numerous previous reports docu-
ment myocardial inflammation as a frequent finding (up to 80%
of patients) in ARVC (3,4). The authors report, surprisingly,
that none of their ARVC patients had accompanying inflam-
mation. Furthermore, the results are not consistent with a
recent report from another Italian group investigating autopsy
material and explanted hearts in geno-positive ARVC patients
(5). That study showed accompanying inflammatory infiltra-
tions in 10 of 10 patients and no evidence of an infective
etiopathogenesis (5). Have the authors considered the possibil-
ity that the inflammatory infiltrations seen in the “myocarditis”
group are part of the ARVC phenotype and that fibrofatty
replacements may occur later in the course of the disease? This
possible difference in disease development may also explain the
benign course seen in the group in the relatively short follow-up
period.
. Viral genome in the myocardium. Five of the 15 patients
classified as having myocarditis had the presence of viral
genome (parvo B19 virus in 3 cases, influenza virus in 2 cases)
in the myocardium documented by PCR. Different viruses may
persist in asymptomatic individuals without being pathogenic.
A recent report from Italy showed 12 of 19 asymptomatic
individuals had detectable parvo B19 deoxyribonucleic acid in
their myocardium (6). In addition, ARVC patients may have
increased susceptibility of having myocarditis as a secondary
phenomenon.
. Molecular genetics. No mutation screening of desmosomal
genes was performed. Given the lack of reference diagnostic
modality for ARVC, the frequency of desmosomal mutations in
both groups is highly relevant. A positive molecular genetics
finding in the “myocarditis” group would reclassify the patient
into the “ARVC” group.
Based on the abovementioned observations, the results pre-
ented by Pieroni et al. (1) should be confirmed in larger ARVC
ohorts with supplementary desmosomal mutation screening.
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iagnosis of Myocarditis
imicking Arrhythmogenic
ight Ventricular Cardiomyopathy
he Role of Endomyocardial Biopsy
uided by Electroanatomic Voltage Map
ieroni et al. (1) recently reported a 50% prevalence of right
entricular (RV) myocarditis in a cohort of 30 patients fulfilling
tandardized diagnostic criteria for arrhythmogenic right ventric-
lar cardiomyopathy (ARVC). The differential diagnosis between
yocarditis and ARVC was obtained by performing electroana-
omic mapping of the RV and then focusing, “for the first time,”
n endomyocardial biopsy (EMB) on selected pathological areas
haracterized by low-voltage potentials (electroanatomic mapping-
uided EMB). Adopting this “novel diagnostic technique,” Pieroni
t al. (1) significantly modified the initial ARVC diagnosis.
We would like to make some comments regarding this study
nd its results. First, to the best of our knowledge, this is not the
rst report describing the electroanatomic mapping-guided EMB
ince this “novel diagnostic technique” has already been exhaus-
ively described by our group (2,3). In particular, in 2008, we
ublished the first report (3) documenting the feasibility of RV
oltage mapping-guided EMB in a series of 16 consecutive
atients with clinical evidence or suspicion for ARVC.
Second, contrary to the findings reported by Pieroni et al. (1), in
ur study (3), we did not observe histological evidence of myocar-
itis in any of the 16 patients with clinical evidence or suspicion for
RVC, in whom a pathological RV voltage map was documented.
p to now, we have been performing EMB targeting RV low-
oltage areas in more than 40 patients with clinical evidence or
uspicion for ARVC, and we have never observed evidence of
ctive or borderline myocarditis according to the Dallas criteria.
ur findings, in agreement with the observations of Corrado et al.
4), seem logical: since myocarditis usually has a patchy distribu-
ion in the heart chambers, it is unlikely to produce solid
ransmural scars detectable as low-voltage areas with endocardial
lectroanatomic mapping.
Third, in the study of Pieroni et al. (1), the most frequently
nvolved RV regions (Table 2 of their study), in descending order,
ere the outflow tract (77%), the anterior free wall (50%), and the
osteroinferior wall (43%), whereas the RV apex and the septal
all were less frequently involved (13% and 3%, respectively).
oherently, the authors included in the article 2 RV voltage maps,
btained from representative patients with ARVC (Fig. 2D of
heir study) and myocarditis (Fig. 3D of their study), both showing
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August 11, 2009:661–8athological areas in RV free wall and outflow tract, but normal
otentials in the apex. Nevertheless, the authors provided in the
rticle only a fluoroscopic demonstration of biopsy sampling in the
V apex (Fig. 1 of their study) but not a demonstration of biopsy
ampling in the RV free wall or outflow tract, as we did in our
tudy (3).
Finally, in the Discussion section, Pieroni et al. (1) stated:
With regard to the safety of the invasive procedure, we must
cknowledge that the high experience level of the cardiologist
erforming the biopsies could have minimized the risks related to
his new approach. . . .” In our opinion, this statement is method-
logically misleading since, in order to reduce the risk profile of the
oltage-guided biopsy procedure, the crucial point is to perform
he sampling on the border zone and not on the thinner core of
ow-voltage areas, as we suggested in our study (3).
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eply
e thank the 3 different groups for their interest in our recent paper
1). In the first 2 letters, Drs. Thomas and Tavares and Drs.
hristensen and Svendsen focus on the potential relationship between
yocarditis and arrhythmogenic right ventricular cardiomyopathy
ARVC) and on the role of genetics in clarifying this issue. We agree
hat this complex “menage a trois” remains an open task, but some
ndings in our study could shed some light. In the last years, some
ave hypothesized that fibrofatty replacement represents the conse-
uence of myocyte apoptosis induced by right ventricular (RV)
yocarditis or that myocardial inflammation whenever observed is a
eaction to myocyte apoptosis caused by genetic abnormalities, or
ather that myocarditis may superimpose on a genetically abnormal
yocardium, possibly accelerating the fibrofatty replacement or even
riggering ventricular arrhythmias. In our study, we never observed
brofatty replacement in endomyocardial biopsies (EMB) of patients bith a histological diagnosis of myocarditis, as well as no evidence of
nflammatory infiltrates or viral genome was documented in myocar-
ial samples from ARVC patients. Of note, EMB were drawn from
lectrically abnormal areas, thus it appears unlikely that fibrofatty
eplacement, not observed in these biopsies, could have been present
lsewhere. As observed in the abstract quoted by Drs. Thomas and
avares, the association of focal inflammatory infiltrates and fibrofatty
eplacement is frequently observed in autopsy studies when the whole
V is analyzed but is uncommon in EMBs. In a recent elegant study
y the Padua group (2), patchy focal myocarditis was observed only in
of 20 ARVC explanted hearts submitted to extensive biopsy
ampling in multiple RV sites, including outflow tract and free wall.
ur findings suggest that with the novel biopsy approach described,
e were able to identify 2 distinct subgroups of patients with different
yocardial disorders.
We agree that genetic analysis could add further information,
ut this could not be conclusive as we would not be able to exclude
he presence of mutations in genes currently not associated with
RVC. Moreover, this approach should be ideally completed by
enetic and histologic studies in asymptomatic relatives carrying
he same mutation of the probands, but not presenting morpho-
ogical, functional, and electrical abnormalities of the RV. In fact,
imilar to other disorders such as hypertrophic cardiomyopathy,
he ideal setting to study the pathophysiology of ARVC and the
ole of genetic and environmental factors, we think would be
epresented by large families with more individuals harboring the
ame genetic defect but showing strikingly different clinical fea-
ures, ranging from severe arrhythmic manifestations and RV
bnormalities, to asymptomatic state in the presence of normal
V. In this context, a complete genetic, electrophysiological,
istological, ultrastructural (i.e., electron microscopy to evaluate
he presence of preclinical desmosomal abnormalities), and viro-
ogical evaluation of all carriers of a gene defect could provide
rucial data on the pathophysiology of the disease. This kind of
tudy, obviously, raises important ethical concerns regarding the
xecution of invasive studies in asymptomatic young subjects
arboring a gene defect.
In patients with histological evidence of myocarditis, the sig-
ificance of viral genome persistence in myocardium is still debated
ith regard to the pathogenic role of some viruses, in particular
arvovirus B19. Nevertheless, in the presence of myocardial
nflammation, the persistence of viral genome strongly suggests the
ssociation between inflammation and viral infection. On the other
and, the detection of viral genome in myocardium of currently
asymptomatic” patients reported in some studies does not exclude
hat these subjects experienced some cardiovascular symptoms
elated to cardiac infection by parvovirus in previous years or rather
hat genome persistence is the hallmark of a previous self-limiting
symptomatic myocarditis.
In the third letter, Drs. Avella and d’Amati raise some meth-
dological issues, allowing us to further discuss some important
spects of our innovative study.
With regard to the site of execution of EMB, it is important to
ighlight some relevant issues that distinguish our study from the
ore-limited imaging characterization adopted by Drs. Avella and
’Amati. At variance with their approach, in our series, all patients
nderwent cardiac magnetic resonance imaging (MRI) to define
V anatomy and function, and all were submitted to RV angiog-
aphy before electroanatomic mapping. In particular, this sequence
n invasive study allows to obtain maps more accurate than usual,
y reaching apical and free wall intertrabecular recesses (visualized
